Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

Go back to Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology
(NASDAQ: ELTX) Delayed: 2.80 -0.5 (15.15%)
Previous Close $3.30    52 Week High
Open $3.30    52 Week Low
Day High $3.32    P/E N/A 
Day Low $2.77    EPS
Volume 1,407,099